These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27791271)

  • 21. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress.
    Scher MB; Vaquero A; Reinberg D
    Genes Dev; 2007 Apr; 21(8):920-8. PubMed ID: 17437997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirtuin 3 induces apoptosis and necroptosis by regulating mutant p53 expression in small‑cell lung cancer.
    Tang X; Li Y; Liu L; Guo R; Zhang P; Zhang Y; Zhang Y; Zhao J; Su J; Sun L; Liu Y
    Oncol Rep; 2020 Feb; 43(2):591-600. PubMed ID: 31894331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease.
    Ansari A; Rahman MS; Saha SK; Saikot FK; Deep A; Kim KH
    Aging Cell; 2017 Feb; 16(1):4-16. PubMed ID: 27686535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging.
    Giralt A; Villarroya F
    Biochem J; 2012 May; 444(1):1-10. PubMed ID: 22533670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10.
    Yang Y; Cimen H; Han MJ; Shi T; Deng JH; Koc H; Palacios OM; Montier L; Bai Y; Tong Q; Koc EC
    J Biol Chem; 2010 Mar; 285(10):7417-29. PubMed ID: 20042612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulated cellular redox status during hyperammonemia causes mitochondrial dysfunction and senescence by inhibiting sirtuin-mediated deacetylation.
    Mishra S; Welch N; Karthikeyan M; Bellar A; Musich R; Singh SS; Zhang D; Sekar J; Attaway AH; Chelluboyina AK; Lorkowski SW; Roychowdhury S; Li L; Willard B; Smith JD; Hoppel CL; Vachharajani V; Kumar A; Dasarathy S
    Aging Cell; 2023 Jul; 22(7):e13852. PubMed ID: 37101412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PM2.5 contributed to pulmonary epithelial senescence and ferroptosis by regulating USP3-SIRT3-P53 axis.
    Li N; Xiong R; Li G; Wang B; Geng Q
    Free Radic Biol Med; 2023 Aug; 205():291-304. PubMed ID: 37348684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirtuin 3 in renal diseases and aging: From mechanisms to potential therapies.
    Peng X; Ni H; Kuang B; Wang Z; Hou S; Gu S; Gong N
    Pharmacol Res; 2024 Aug; 206():107261. PubMed ID: 38917912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of inhibition of the human sirtuin enzyme SIRT3 by nicotinamide: computational and experimental studies.
    Guan X; Lin P; Knoll E; Chakrabarti R
    PLoS One; 2014; 9(9):e107729. PubMed ID: 25221980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.
    Zhang YY; Zhou LM
    Biochem Biophys Res Commun; 2012 Jun; 423(1):26-31. PubMed ID: 22609775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.
    Nogueiras R; Habegger KM; Chaudhary N; Finan B; Banks AS; Dietrich MO; Horvath TL; Sinclair DA; Pfluger PT; Tschöp MH
    Physiol Rev; 2012 Jul; 92(3):1479-514. PubMed ID: 22811431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylation of HDAC1 and degradation of SIRT1 form a positive feedback loop to regulate p53 acetylation during heat-shock stress.
    Yang H; Yan B; Liao D; Huang S; Qiu Y
    Cell Death Dis; 2015 May; 6(5):e1747. PubMed ID: 25950477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirt3 is a tumor suppressor in lung adenocarcinoma cells.
    Xiao K; Jiang J; Wang W; Cao S; Zhu L; Zeng H; Ouyang R; Zhou R; Chen P
    Oncol Rep; 2013 Sep; 30(3):1323-8. PubMed ID: 23842789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease.
    Zhou ZD; Tan EK
    Ageing Res Rev; 2020 Sep; 62():101107. PubMed ID: 32535274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are sirtuins markers of ovarian aging?
    Zhang J; Fang L; Lu Z; Xiong J; Wu M; Shi L; Luo A; Wang S
    Gene; 2016 Jan; 575(2 Pt 3):680-6. PubMed ID: 26403315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1.
    Wong S; Weber JD
    Biochem J; 2007 Nov; 407(3):451-60. PubMed ID: 17620057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research advances in the association between deacetylase Sirtuin3 and liver diseases].
    Yu J; Chen C; Wang WX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):948-951. PubMed ID: 28073422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuins and p53.
    van Leeuwen I; Lain S
    Adv Cancer Res; 2009; 102():171-95. PubMed ID: 19595309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic organization and localization of the NAD-dependent histone deacetylase gene sirtuin 3 (Sirt3) in the mouse.
    Mahlknecht U; Voelter-Mahlknecht S
    Int J Oncol; 2011 Mar; 38(3):813-22. PubMed ID: 21165558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer.
    Chen Y; Fu LL; Wen X; Wang XY; Liu J; Cheng Y; Huang J
    Cell Death Dis; 2014 Feb; 5(2):e1047. PubMed ID: 24503539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.